WCLD vs XBI
WisdomTree Cloud Computing Fund vs SPDR S&P Biotech ETF
- • XBI has the lower expense ratio at 0.35% vs 0.45% for WCLD.
- • XBI pays a higher dividend yield (0.36%).
Side-by-side metrics
| Metric | WCLD | XBI |
|---|---|---|
Expense ratio Annual fee. Lower is better. | 0.45% | 0.35% |
Dividend yield Trailing 12-month yield. | 0.00% | 0.36% |
AUM Assets under management — bigger funds are typically more liquid. | $245M | $10.73B |
YTD return | -3.57% | 33.79% |
1-year return | — | — |
3-year return Annualized. | — | — |
5-year return Annualized. | — | — |
10-year return Annualized. | — | — |
Beta (3Y) Volatility relative to the market. Closer to 1 = market-like. | 1.20 | 1.10 |
P/E ratio | 31.46 | — |
Last price | $34.32 | $164.01 |
Inception | — | — |
Issuer | WisdomTree | State Street |
WCLD top holdings
| DOCN | DigitalOcean Holdings Inc | 3.28% |
| FROG | JFrog Ltd Ordinary Shares | 3.20% |
| PANW | Palo Alto Networks Inc | 3.04% |
| DDOG | Datadog Inc Class A | 2.99% |
| CRWD | CrowdStrike Holdings Inc Class A | 2.61% |
| TENB | Tenable Holdings Inc | 2.46% |
| OKTA | Okta Inc Class A | 2.44% |
| TWLO | Twilio Inc Class A | 2.42% |
| RBRK | Rubrik Inc Class A Shares | 2.12% |
| QLYS | Qualys Inc | 1.97% |
XBI top holdings
| APGE | Apogee Therapeutics Inc | 1.49% |
| MRNA | Moderna Inc | 1.41% |
| TWST | Twist Bioscience Corp | 1.41% |
| ORKA | Oruka Therapeutics Inc | 1.38% |
| KYMR | Kymera Therapeutics Inc Ordinary Shares | 1.36% |
| VKTX | Viking Therapeutics Inc | 1.30% |
| PRAX | Praxis Precision Medicines Inc Ordinary Shares | 1.29% |
| ERAS | Erasca Inc | 1.27% |
| RVMD | Revolution Medicines Inc Ordinary Shares | 1.20% |
| RYTM | Rhythm Pharmaceuticals Inc | 1.20% |
About WCLD
WCLD (WisdomTree Cloud Computing Fund) is Pure-play cloud software companies. Managed by WisdomTree, the fund carries $245M in assets under management, an expense ratio of 0.45%. Its largest holding is DigitalOcean Holdings Inc (DOCN), which represents 3.3% of the portfolio. Technology is the fund's largest sector exposure at 97.2%.
About XBI
XBI (SPDR S&P Biotech ETF) is Equal-weight biotech stocks in the S&P Biotech Index. Managed by State Street, the fund carries $10.7B in assets under management, an expense ratio of 0.35%, a dividend yield of 0.36%. Its largest holding is Apogee Therapeutics Inc (APGE), which represents 1.5% of the portfolio. Financial Services is the fund's largest sector exposure at 0.5%.